Eli Lilly

Eli Lilly to buy gene therapy company Akouos for $487 million

27 Oct 2022

Eli Lilly to acquire Loxo Oncology for $8 bn in cash

09 Jan 2019

Loxo’s oncology drug Vitrakvi, priced at $32,800 per month, and experimental follow-up drug LOXO-195, on which Bayer is also a partner, together could generate annual sales of about $750 million

Eli Lilly to buy privately-held AurKa Pharma in a deal potentially worth $575 mn

14 May 2018

Eli Lilly to buy Armo BioSciences for $1.6 bn

11 May 2018

US pharmaceutical company Eli Lilly and Co yesterday struck a deal to buy Armo BioSciences Inc for about $1.6 billion in order to strengthen its immuno-oncology portfolio

Eli Lilly to buy Boehringer Ingelheim's US pet vaccines business for $885 mn

05 Oct 2016

Eli Lilly’s stock hit after evacetrapib study ended

13 Oct 2015

Eli Lilly wins key cancer drug patent case in UK

26 Jun 2015

Eli Lily to divest US veterinary assets to Virbac

27 Oct 2014

Takeda Pharmaceutical Co, Eli Lilly lose $9 bn damages over Actos drug

30 Aug 2014

Eli Lilly to buy Novartis AG's animal health business for $5.4 bn

22 Apr 2014

Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.

Eli Lilly’s Elanco to buy Germany’s Lohmann Animal Health

25 Feb 2014

Eli Lilly to lay off around 1,000 sales personnel in US

12 Apr 2013

Strides Arcolab, Eli Lilly to collaborate on cancer drug delivery

05 Dec 2012

Eli Lilly ties up with Lupin to push diabetes drug sales

29 Jul 2011

HCL, Eli Lilly open Co-Innovation Lab in Singapore

14 Jul 2011

EU regulator approves Eli Lilly’s acquisition of J&J’s animal health unit

07 Jul 2011

Eli Lilly to acquire Johnson & Johnson’s animal health unit

15 Mar 2011

Eli Lilly's $800-mn Avid deal boosts diagnostic capabilities

09 Nov 2010

Privately held Avid is a developer of new molecular imaging agents that aid medical management of chronic human diseases

US court favours Sun Pharma over Eli Lilly’s cancer drug patent on

29 Jul 2010

Eli Lilly inks $335 million licensing deal with Australia’s Acrux

17 Mar 2010

Eli Lilly’s Elanco takes over Pfizer’s European animal health portfolio

09 Mar 2010

Eli Lilly wins drug patent case vs Dr Reddy's in UK

18 Dec 2009

Jubilant and Eli Lilly extend collaboration for five years

01 Dec 2009

Eli Lilly to hive off Tippecanoe laboratory to Evonik Industries

15 Oct 2009

Lilly says its strategic decision was to purchase, rather than manufacture, many late-stage chemical intermediates, and the evolution of the Lilly pipeline towards more biotech medicines

Academia Sinica joins Eli Lilly's new TB drug discovery programme

30 Sep 2009